Transforming growth factor (TGF)-β, like VEGF [11, 12], could cause PAI-1/tPA imbalance and disordered fibrin turnover, and intrapleural injection with anti-TGF-β antibody has been shown to decrease pleural fibrosis in experimental empyema in rabbits [34]. Here, VEGFA is linked to empyema.